Back to top

The technical outlook for SPRY is unchanged after it rises 7.81% on July 2

ARS Pharmaceuticals, Inc. (SPRY) — SwingTradeBot Technical Analysis Report · Jul 2, 2026, 17:50 ET
SPRY closed up 7.81% on Thursday, July 2nd, with volume running 0.2× below average. Key support levels exist at 8.16, 7.77 & 7.54, with resistance at 8.78, 9.01 & 9.4. Slow Stochastic readings suggest the stock is currently oversold.

Current SwingTradeBot Technical Rating of SPRY: D

Is this the only signal? Not even close. Explore the full breakdown at SwingTradeBot.

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ARS Pharmaceuticals, Inc. (SPRY)